| |
| |
|
| Insider
Information: |
Tung Roger D |
| Relationship: |
Chief Executive Office... |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Concert Pharmaceuticals, Inc. |
CNCE |
Chief Executive Office... |
2023-03-06 |
0 |
2023-03-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(147,536) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(57,916) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(756,427) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2023-01-06 |
4 |
AS |
$7.24 |
$66,898 |
D/D |
(9,240) |
971,018 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2022-02-15 |
4 |
AS |
$3.09 |
$41,653 |
D/D |
(13,480) |
980,258 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
208,900 |
993,738 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2022-01-06 |
4 |
AS |
$3.09 |
$28,552 |
D/D |
(9,240) |
784,838 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2021-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,500 |
794,078 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2021-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
801,578 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2021-12-13 |
4 |
OE |
$3.50 |
$23,450 |
D/D |
6,700 |
815,278 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2021-12-13 |
4 |
AS |
$3.62 |
$24,254 |
D/D |
(6,700) |
808,578 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2021-02-17 |
4 |
AS |
$7.20 |
$97,056 |
D/D |
(13,480) |
808,578 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
69,300 |
822,058 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2020-03-13 |
4 |
OE |
$3.79 |
$55,338 |
D/D |
14,601 |
752,758 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
101,100 |
738,157 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2019-12-04 |
4 |
OE |
$4.41 |
$58,062 |
D/D |
13,166 |
644,686 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2019-12-04 |
4 |
D |
$7.61 |
$58,057 |
D/D |
(7,629) |
637,057 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2019-04-10 |
4 |
OE |
$4.41 |
$109,747 |
D/D |
24,886 |
616,919 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2019-03-31 |
4 |
D |
$12.07 |
$71,092 |
D/D |
(5,890) |
592,033 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2018-06-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
597,923 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2018-03-31 |
4/A |
D |
$22.90 |
$134,881 |
D/D |
(5,890) |
598,923 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2018-03-31 |
4 |
D |
$22.90 |
$134,881 |
D/D |
(5,890) |
638,923 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2018-03-02 |
4 |
D |
$21.04 |
$127,124 |
D/D |
(6,042) |
644,813 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2018-03-02 |
4 |
OE |
$4.58 |
$127,127 |
D/D |
27,757 |
650,855 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Executive Officer |
• • – |
2017-11-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,600 |
623,098 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
